115 related articles for article (PubMed ID: 8821591)
21. Sub-MIC ciprofloxacin effect on fimbrial production by uropathogenic Escherichia coli strains.
Lo Bue AM; Geremia E; Castagna C; Chisari G; Nicoletti G
J Chemother; 1999 Oct; 11(5):357-62. PubMed ID: 10632381
[TBL] [Abstract][Full Text] [Related]
22. [Alteration of antibacterial activity of tosufloxacin and various antibacterial agents against Streptococcus pneumoniae].
Maekawa M; Fukuda Y; Sugiura Y; Kamiyama T; Futakuchi N; Takahata M; Mitsuyama J
Jpn J Antibiot; 2003 Feb; 56(1):27-35. PubMed ID: 12723396
[TBL] [Abstract][Full Text] [Related]
23. Influence of sub-inhibitory concentrations of antibacterials on the surface properties and adhesion of Escherichia coli.
Loubeyre C; Desnottes JF; Moreau N
J Antimicrob Chemother; 1993 Jan; 31(1):37-45. PubMed ID: 8444673
[TBL] [Abstract][Full Text] [Related]
24. Effects of sub-minimum inhibitory concentrations of gatifloxacin on the inhibition of Staphylococcus aureus and Escherichia coli adherence.
Braga PC; Dal Sasso M
Arzneimittelforschung; 2002; 52(2):109-12. PubMed ID: 11878198
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells.
Zafriri D; Ofek I; Adar R; Pocino M; Sharon N
Antimicrob Agents Chemother; 1989 Jan; 33(1):92-8. PubMed ID: 2653218
[TBL] [Abstract][Full Text] [Related]
26. Norfloxacin decreases bacterial adherence of quinolone-resistant strains of Escherichia coli isolated from patients with cirrhosis.
Gascón I; Pascual S; Plazas J; Sánchez J; Francés R; Más P; Zapater P; Pérez-Mateo M; Such J
Aliment Pharmacol Ther; 2005 Mar; 21(6):701-7. PubMed ID: 15771756
[TBL] [Abstract][Full Text] [Related]
27. Adherence of Escherichia coli to sperm: a mannose mediated phenomenon leading to agglutination of sperm and E. coli.
Wolff H; Panhans A; Stolz W; Meurer M
Fertil Steril; 1993 Jul; 60(1):154-8. PubMed ID: 8513934
[TBL] [Abstract][Full Text] [Related]
28. An investigation of the factors involved in increased adherence of C. albicans to epithelial cells mediated by E. coli.
Makrides HC; MacFarlane TW
Microbios; 1983; 38(153-154):177-85. PubMed ID: 6139740
[TBL] [Abstract][Full Text] [Related]
29. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
Zinner SH; Vostrov SN; Alferova IV; Lubenko IY; Portnoy YA; Firsov AA
Int J Antimicrob Agents; 2004 Aug; 24(2):173-7. PubMed ID: 15288317
[TBL] [Abstract][Full Text] [Related]
30. Analysis of macromolecular biosynthesis to define the quinolone-induced postantibiotic effect in Escherichia coli.
Guan L; Blumenthal RM; Burnham JC
Antimicrob Agents Chemother; 1992 Oct; 36(10):2118-24. PubMed ID: 1280055
[TBL] [Abstract][Full Text] [Related]
31. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
[TBL] [Abstract][Full Text] [Related]
32. Interactions of the 4-quinolones with other antibacterials.
Lewin CS; Smith JT
J Med Microbiol; 1989 Jul; 29(3):221-7. PubMed ID: 2664184
[TBL] [Abstract][Full Text] [Related]
33. In-vitro activity of OPC-17116 against bacterial enteric pathogens.
Arduino RC; Frosolono M; Murray BE
J Antimicrob Chemother; 1994 Sep; 34(3):403-7. PubMed ID: 7829414
[No Abstract] [Full Text] [Related]
34. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
Qadri SM; Lee GC; Ellis ME
Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
[TBL] [Abstract][Full Text] [Related]
35. Bactericidal activity of enoxacin and lomefloxacin against Escherichia coli KL16.
Lewin CS; Amyes SG; Smith JT
Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):731-3. PubMed ID: 2506044
[TBL] [Abstract][Full Text] [Related]
36. Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates.
Sader HS; Streit JM; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2004 Aug; 49(4):283-7. PubMed ID: 15313534
[TBL] [Abstract][Full Text] [Related]
37. [Effect of subinhibitory levels of aminoglycosides and fluoroquinolines on hydrophobicity and motility of Serratia marcescens].
Majtán V; Majtánová L
Epidemiol Mikrobiol Imunol; 2001 Feb; 50(1):26-30. PubMed ID: 11233670
[TBL] [Abstract][Full Text] [Related]
38. Mannose-sensitive stimulation of human leukocyte chemiluminescence by Escherichia coli.
Mangan DF; Snyder IS
Infect Immun; 1979 Dec; 26(3):1014-9. PubMed ID: 43285
[TBL] [Abstract][Full Text] [Related]
39. [Effect of subinhibitory concentrations of antibacterial agents on the adherence of fimbriated Escherichia coli to uroepithelial cells].
Padilla Espinosa C; Brevis P; Zemelman R; Vivaldi E
Rev Latinoam Microbiol; 1988; 30(1):5-9. PubMed ID: 2902677
[No Abstract] [Full Text] [Related]
40. [Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative].
Koikeda S; Okabe H; Shibata H; Hase T; Nakanishi N; Okezaki E; Kato H; Masamune Y
Jpn J Antibiot; 1989 Jan; 42(1):193-9. PubMed ID: 2468799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
